Shixiang Su - Search Results

Year	Number of Results
2006	1
2007	1
2008	1
2011	1
2015	1
2016	1
2018	2
2019	2
2020	6
2021	7
2022	7
2023	7
2024	3

1

CAR‑T cell therapy: A breakthrough in traditional cancer treatment strategies (Review).

Sun D, Shi X, Li S, Wang X, Yang X, Wan M. Sun D, et al. Among authors: shi x. Mol Med Rep. 2024 Mar;29(3):47. doi: 10.3892/mmr.2024.13171. Epub 2024 Jan 26. Mol Med Rep. 2024. PMID: 38275119 Free PMC article. Review.

2

Targeting Endocytosis and Cell Communications in the Tumor Immune Microenvironment.

Wu B, Wang Q, Shi X, Jiang M. Wu B, et al. Among authors: shi x. Cell Commun Signal. 2022 Oct 18;20(1):161. doi: 10.1186/s12964-022-00968-3. Cell Commun Signal. 2022. PMID: 36258231 Free PMC article. Review.

3

Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment.

Wu B, Shi X, Jiang M, Liu H. Wu B, et al. Among authors: shi x. Mol Cancer. 2023 Feb 21;22(1):38. doi: 10.1186/s12943-023-01748-4. Mol Cancer. 2023. PMID: 36810098 Free PMC article. Review.

4

Multidirectional characterization of cellular composition and spatial architecture in human multiple primary lung cancers.

Wang Y, Chen D, Liu Y, Shi D, Duan C, Li J, Shi X, Zhang Y, Yu Z, Sun N, Wang W, Ma Y, Xu X, Otkur W, Liu X, Xia T, Qi H, Piao HL, Liu HX. Wang Y, et al. Among authors: shi x. Cell Death Dis. 2023 Jul 25;14(7):462. doi: 10.1038/s41419-023-05992-w. Cell Death Dis. 2023. PMID: 37488117 Free PMC article.

5

Hierarchical helical carbon nanotube fibre as a bone-integrating anterior cruciate ligament replacement.

Wang L, Wan F, Xu Y, Xie S, Zhao T, Zhang F, Yang H, Zhu J, Gao J, Shi X, Wang C, Lu L, Yang Y, Yu X, Chen S, Sun X, Ding J, Chen P, Ding C, Xu F, Yu H, Peng H. Wang L, et al. Among authors: shi x. Nat Nanotechnol. 2023 Sep;18(9):1085-1093. doi: 10.1038/s41565-023-01394-3. Epub 2023 May 4. Nat Nanotechnol. 2023. PMID: 37142709

6

The Pathological Mechanism and Potential Application of IL-38 in Autoimmune Diseases.

Han MM, Yuan XR, Shi X, Zhu XY, Su Y, Xiong DK, Zhang XM, Zhou H, Wang JN. Han MM, et al. Among authors: shi x. Front Pharmacol. 2021 Sep 2;12:732790. doi: 10.3389/fphar.2021.732790. eCollection 2021. Front Pharmacol. 2021. PMID: 34539413 Free PMC article. Review.

7

KEAP1 promotes anti-tumor immunity by inhibiting PD-L1 expression in NSCLC.

Li J, Shi D, Li S, Shi X, Liu Y, Zhang Y, Wang G, Zhang C, Xia T, Piao HL, Liu HX. Li J, et al. Among authors: shi x. Cell Death Dis. 2024 Feb 27;15(2):175. doi: 10.1038/s41419-024-06563-3. Cell Death Dis. 2024. PMID: 38413563 Free PMC article.

8

Cascade diversification directs generation of neuronal diversity in the hypothalamus.

Zhang YH, Xu M, Shi X, Sun XL, Mu W, Wu H, Wang J, Li S, Su P, Gong L, He M, Yao M, Wu QF. Zhang YH, et al. Among authors: shi x. Cell Stem Cell. 2021 Aug 5;28(8):1483-1499.e8. doi: 10.1016/j.stem.2021.03.020. Epub 2021 Apr 21. Cell Stem Cell. 2021. PMID: 33887179 Free article.

9

Geographic variations in idiopathic epiretinal membranes in China.

Xu M, Zhou M, Sun X, Shi X. Xu M, et al. Among authors: shi x. Ann Transl Med. 2021 Jun;9(11):938. doi: 10.21037/atm-21-2722. Ann Transl Med. 2021. PMID: 34350253 Free PMC article.

The distribution pattern of ERM in China and the overview of the factors affecting the surgery approaches of multicenter surgeons were shown. The findings of this study will contribute to the formulation of medical policies, and provide insights into the healthcare environ …

The distribution pattern of ERM in China and the overview of the factors affecting the surgery approaches of multicenter surgeons wer …

10

An aminopeptidase N-activatable chemiluminescence probe for image-guided surgery and metastasis tracking of tumor.

Shi X, Deng Y, Liu X, Gao G, Wang R, Liang G. Shi X, et al. Biosens Bioelectron. 2022 Jul 15;208:114212. doi: 10.1016/j.bios.2022.114212. Epub 2022 Mar 31. Biosens Bioelectron. 2022. PMID: 35378458

Nevertheless, tiny residual tumor lesions and distant metastases are always missed during surgery, resulting in tumor recurrence. Therefore, it is important for doctors to distinguish residual tumor tissues and distant metastases from normal tissues but remains challenging …

Nevertheless, tiny residual tumor lesions and distant metastases are always missed during surgery, resulting in tumor recurrence. The …

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

36 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year